Literature DB >> 8159010

Eccrine porocarcinoma.

T A Goedde1, H Bumpers, J Fiscella, U Rao, C P Karakousis.   

Abstract

Eccrine porocarcinoma, a malignancy of the eccrine sweat glands, is extremely rare. Our report and a review of the literature (70 cases) emphasize the features of this tumor. Age at time of treatment ranged from 19 to 94 years (mean 67 years). Duration of the lesion ranged from two months to 50 years; 31 (44%) had the lesion present > or = 5 years. Forty-four patients (62%) had tumors located on the extremities, 13 (19%) on the head and neck region and 12 (17%) on the trunk. All patients whose race is known were white. Primary treatment should consist of wide local excision and regional lymphadenectomy, if clinically indicated. Although there is a significant risk of cutaneous, regional lymph node, or visceral metastases, the value of elective or therapeutic regional lymphadenectomy is unknown, as is the role of adjunctive therapy.

Entities:  

Mesh:

Year:  1994        PMID: 8159010     DOI: 10.1002/jso.2930550413

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Eccrine porocarcinoma: A case report and review of the literature.

Authors:  Mark Sheldon Lloyd; Naguib El-Muttardi; A Robson
Journal:  Can J Plast Surg       Date:  2003

2.  Eccrine porocarcinoma of the lower extremity: a case report and review of literature.

Authors:  Oliver Chang; Ashraf Elnawawi; Bernard Rimpel; Armand Asarian; Nadeem Chaudhry
Journal:  World J Surg Oncol       Date:  2011-08-22       Impact factor: 2.754

3.  Treatment of eccrine porocarcinoma with metastasis to the parotid gland using intensity-modulated radiation therapy: a case report.

Authors:  Youssef H Zeidan; A Jason Zauls; Masha Bilic; Eric J Lentsch; Anand K Sharma
Journal:  J Med Case Rep       Date:  2010-05-22

4.  [Sweat gland eccrine porocarcinoma of the face: a rare annexal tumor].

Authors:  Mohammed Lakouichmi; Mohamed El Bouihi; Ibtissam Zrara; Saad Lahmiti; Nadia Mansouri Hattab
Journal:  Pan Afr Med J       Date:  2013-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.